The evolution of therapeutic modalities drives the adoption of single-use technologies.

Review of SUT Adoption in Biopharma Manufacturing

Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.

Why Are Pharmaceutical Companies Reluctant to Adopt Cloud Technologies?

Given the criticality of fill/finish processes, it is clear that automation is the next technological step.

 Automating the Future of Fill/Finish

Topic

John Schallom is senior technical services Associate, STERIS.

Brian Bosso is technical services manager, STERIS.

Paul Lopolito is a technical services specialist at STERIS, Mentor, OH.

Katie Frey is formulation manager, STERIS.

Amy Thanavaro is R&D scientific manager, STERIS.

Articles

The authors performed interference and enhancement testing using a formulated alkaline and acid cleaner, as well as common biopharmaceutical process residues.

In-line UV Spectrometry Monitoring in Cleaning Validation

Modular process design, single-use technologies, and flexible filling lines are some of the ways manufacturers can combat challenges involved in small-batch manufacturing.

Flexibility Provides Solutions to Small-Batch Manufacturing Challenges

Addressing human interventions to reduce their impact on contamination requires addressing broader considerations than limiting operator activities. Equipment, automation, procedural and component changes can be utilized to make the aseptic activities safer. This article offers suggestions for reducing the adverse impact of intervention throughout the aseptic process.

Interfering with Interventions in Aseptic Processing

Videos

Cross-functional trade compliance planning is critical as pharma braces for broad 232 tariffs and shifting United States-China-India supply dynamics.

How Pharma Can Build Resilient Supply Chains Amid Trade and Tariff Shifts

US pharma firms face higher drug costs, delayed launches, and compliance risks from proposed sectoral tariffs, prompting urgent supply chain reviews.

Trade Policy Shifts: Compliance and Cost Strategies for Pharma

Patrick Lavery is an Editor for the MJH Life Sciences brands 

. Previously at MJH, he filled the same role for 

Following an overhaul at ACIP, the HHS secretary took the advice of the committee’s new members, saying he was acting on guidance that dated back to 1999.

Opposing Reactions as RFK Jr. Removes Thimerosal from Flu Vaccines

In this exclusive Drug Digest video, Deepak Bahl from Roquette and Jagruti Patel from Lonza look at strategies for accelerating early-stage development while reducing risk, approaches to speeding up timelines for complex formats without sacrificing quality, and maintaining a flexible CMC process that ensures quality.

Drug Digest: Speed, Flexibility Top Large-Molecule Manufacturing Trends

US pharma tariffs may start low and rise, risking drug shortages, higher costs, and pressure on generics amid reshoring push.

Tariffs & Trade Policy: What to Watch for, Cost Impacts, and Supply Chain Strategies

The trade show is expected to draw 35,000 attendees to a show floor netting more than 1 million square feet.

Pack Expo Las Vegas Marks 30th Anniversary with New Experiences for 2025

The company will build a multi-billion-dollar drug manufacturing center in Virginia that will focus on chronic diseases, as well as facilities in California, Indiana, Maryland, Massachusetts, and Texas.